Opinion: WHO pandemic threat director: Here’s what needs to happen to combat mpox
There is a pervasive myth that the Democratic Republic of the Congo and other countries…
Category: vaccines
STAT+: Moderna touts research progress as it cuts R&D spending by $1.1 billion
Moderna said Thursday it would cut its annual spending on research and development by 23%,…
Opinion: Gaza polio vaccination drive must include measles shots
We have each worked on childhood vaccination programs in both development and humanitarian emergency settings…
Opinion: The alliance between RFK Jr. and Trump all comes down to their health-related worldview
Robert F. Kennedy Jr.’s priorities may seem like a random grab bag of contrarianism, conspiracies,…
After decades of anti-vaccine rhetoric, RFK Jr. pivots to chronic diseases — and gets Trump on board
WASHINGTON — Last month, before he called it quits on a presidential run, Robert F….
Opinion: To stop mpox from becoming the next pandemic, we must address global vaccine inequities
In early 2022, I cared for one of the first patients with mpox in Massachusetts….
WHO launches plan to stanch mpox transmission and says the virus can be stopped
The U.N. health agency on Monday launched a six-month plan to help stanch outbreaks of…
Merck Ebola vaccine Ervebo shown to offer substantial protection
Merck’s Ebola vaccine offered substantial protection to people vaccinated during the 2018-2020 outbreak in the…
To counter mpox, vaccine maker could ramp up by another 8 million doses next year
When mpox first began to spread internationally in 2022, affected countries scrambled to buy some…
Abortion, shingles, extreme heat, and sudden cardiac arrest
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in…
Opinion: Better safety studies could restore America’s confidence in vaccines
In February 2021, I received my second Covid-19 shot — the newly developed vaccine that…
Opinion: Letters on Sonya Massey’s death, vaccine injuries, and much more
First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the…
4 takeaways from STAT’s story on the development of malaria vaccines
For the first time, the world is starting to roll out malaria vaccines to children…
Behind the malaria vaccines: A 40-year quest against one of humanity’s biggest killers
Malaria is one of our most ancient foes — and one of the wiliest. Caused…
Bird flu snapshot: Upstart manufacturers in low- and middle-income countries to start early vaccine work
Bird flu snapshot: This is the latest installment in a series of regular updates on…
Vaccination slashes risk of long Covid, says large study tracing cases through Delta and Omicron variants
Vaccination lowers the chance of developing long Covid, according to a large new study that…
Opinion: Listen: Empathy should be the first response to people with vaccine injury, fears
For scientists and medical professionals well versed in the safety and effectiveness of vaccines, it…
GSK buys mRNA-based Covid, flu vaccines from CureVac in restructured partnership
GSK and CureVac have restructured an ongoing partnership that gives the British pharma giant control…
Moderna receives $176 million from BARDA for mRNA influenza vaccines
Moderna has been awarded $176 million by the Biomedical Advanced Research and Development Authority to…
CDC advisory panel opts for a go-slow approach on expanding usage of RSV vaccines
Makers of RSV vaccines for older adults saw their plans to try to expand usage…
On the road to eliminate rabies, Gavi announces plan to improve human vaccination
Rabies has been in global health’s crosshairs for years. Around the world, the viral infection…
A biotech’s binary bet ends badly
Want to stay on top of the science and politics driving biotech today? Sign up to get…
FDA offers new guidelines for Covid-19 vaccine
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: Readers respond to a plea for rare disease progress, vaccine-related injury, and more
First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the…
Opinion: Telling new stories can help people see the value of vaccines
Nearly nine in 10 Americans strongly believe in the overall value of childhood vaccines. Reflecting…
Opinion: Empathy should guide responses to reported vaccine injuries
As a co-leader of the team at the National Institutes of Health that developed technologies…
FDA expands approval for GSK’s RSV vaccine to cover younger at-risk adults
The Food and Drug Administration on Friday expanded the approval for GSK’s vaccine to protect…
Novovax will be able to supply Covid-19 vaccines this fall
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: Close a regulatory loophole in the ACA to provide vaccine access for all Americans
The Patient Protection and Affordable Care Act, (generally known as the ACA), was signed into…
Testing begins for a new form of PrEP
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Finland to offer bird flu vaccine to select groups of people, a possible global first
LONDON — Finland is preparing to offer vaccines to people at risk of exposure to…
Can AstraZeneca make good on its promise?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
In light of H5N1 outbreak, U.S. in talks with mRNA vaccine makers on bird flu
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Maryland takes first steps to cap drug costs
Want to stay on top of the science and politics driving biotech today? Sign up to get…
When should we start making H5N1 vaccine, and who will make that decision? In short, it’s complicated
If the H5N1 bird flu virus ever acquires the ability to transmit easily to and…
Animal studies lend support to an innovative HIV vaccine strategy — but there’s still a long way to go
HIV has long stumped immunologists looking to develop an effective vaccine. All of the most…
AstraZeneca antibody reduced Covid-19 risk in immunocompromised
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: A dose of reality on adult vaccinations
The number of children who received their routine vaccinations declined during the pandemic, so public…
STAT+: Sanofi enters vaccine licensing deal with Novavax, giving beleaguered biotech a lifeline
LONDON — Novavax, the beleaguered maker of a Covid-19 vaccine, just got a boost of…
A new cholera vaccine will increase supply, but will it be enough to manage global outbreaks?
Weeks after the global public health community sounded the alarm on the shortage of cholera…
Massive amounts of H5N1 vaccine would be needed if there’s a bird flu pandemic. Can we make enough?
The unsettling reality of H5N1 bird flu circulating in dairy cow herds in multiple parts…
What about the company Vertex didn’t buy?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Gas prices are hurting biotech
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Pfizer’s plot to win the RSV vaccine race
Want to stay on top of the science and politics driving biotech today? Sign up to get…
People in Republican-voting states more likely to report Covid-19 vaccine side effects, study says
People in Republican-voting states were more likely to report adverse events after receiving a Covid-19…
How will the Supreme Court’s mifepristone decision impact biopharma?
New biotech newsletter launching this Thursday. Don’t miss out. Hey there. Today, we discuss the…
STAT+: During the pandemic, were great vaccines bad business? A company-by-company review
It’s been four years since Covid-19 emerged, igniting a pandemic that killed millions of people…
RSV monoclonal Beyfortus was 90% effective at preventing hospitalizations in children this winter: CDC
A new monoclonal antibody product to protect against respiratory syncytial virus was 90% effective at…
FDA advisory panel recommends a streamlined flu vaccine for next fall
When Americans line up for flu vaccines next fall, they will almost certainly be getting…
The next act for a biotech rainmaker
Want to stay on top of the science and politics driving biotech today? Sign up to…